home · filing · 0001213900-21-059650
8-K filed November 16, 2021, 6:59 PM ET
ticker BJDX
CIK 0001704287
other material
confidence high
sentiment positive
materiality 0.75
Bluejay Diagnostics prices IPO of 2.16M units at $10/unit with warrants
Bluejay Diagnostics, Inc.
IPO of 2,160,000 units at $10 each closed Nov 15; each unit: share, Class A warrant ($7 exercise), Class B warrant ($10 exercise).
Underwriters partially exercise option for additional 324,000 Class A and Class B warrants.
$4.5M of 7.5% Senior Secured Convertible Debentures converted into Series D preferred, convertible into 4.5M common shares; resale registered.
Gary Gemignani appointed to board as independent director, audit committee chair, and compensation committee member.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Filed November 16, 2021, 6:59 PM ET
Gary Gemignani was appointed to the board of directors of the Company.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Gary Gemignani was appointed as Director at Bluejay Diagnostics, Inc..
Action appointed
Role Director
Exact text from the filing
Gary Gemignani was appointed to the board of directors of the Company.
View on SEC.gov
Source: SEC EDGAR
accession 0001213900-21-059650
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.